Cargando…
The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer
Gastric cancer is the sixth most common cancer and is known to be the fifth-leading cause of cancer-related deaths globally in 2018. Systemic therapy remains the only curative option in advanced gastric carcinoma with the primary goal of improving the Health-related Quality of Life (HRQoL) (includin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954857/ https://www.ncbi.nlm.nih.gov/pubmed/32021422 http://dx.doi.org/10.2147/CMAR.S199827 |